Current strategies in immunotherapy for acute myeloid leukemia.

Current strategies in immunotherapy for acute myeloid leukemia.

Item
http://www.wikidata.org/entity/Q38068967
Immunological effects of vaccines combined with granulocyte colony-stimulating factor on a murine WEHI-3 leukemia model.Targeting CD157 in AML using a novel, Fc-engineered antibody construct.T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment.New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia.Recent developments in immunotherapy of acute myeloid leukemia.RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML.The More, The Better: "Do the Right Thing" For Natural Killer Immunotherapy in Acute Myeloid Leukemia.Plasmodium yoelii infection inhibits murine leukaemia WEHI-3 cell proliferation in vivo by promoting immune responses.
P2860

Current strategies in immunotherapy for acute myeloid leukemia.

Item
http://www.wikidata.org/entity/Q38068967
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current strategies in immunotherapy for acute myeloid leukemia.
@en
type
label
Current strategies in immunotherapy for acute myeloid leukemia.
@en
prefLabel
Current strategies in immunotherapy for acute myeloid leukemia.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Current strategies in immunotherapy for acute myeloid leukemia.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921